World's Best Scientists 2026 revealed!
Miguel A. Sanz

Miguel A. Sanz

Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
97
Citations
65419
World Ranking
9064
National Ranking
130

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Miguel A. Sanz is affiliated with the University of Valencia in Spain and has a research focus primarily within the field of Medicine, with a strong specialization in Hematology. Their body of work encompasses a variety of related subfields including Molecular Biology, Genetics, Oncology, and Public Health, Environmental and Occupational Health.

The topics covered in Miguel A. Sanz's research reflect a concentration on hematologic disorders and treatment approaches, including:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Retinoids in leukemia and cellular processes
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Acute Lymphoblastic Leukemia research
  • Histone Deacetylase Inhibitors Research

The scientist has contributed to various publication venues, with several papers appearing frequently in the following journals and platforms:

  • Blood
  • Cancers
  • Transplantation and Cellular Therapy
  • Clinical Lymphoma Myeloma & Leukemia
  • Bone Marrow Transplantation

Some of Miguel A. Sanz's recent papers include:

  • "Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene," 2020, published in Cancers
  • "Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial," 2021, published in Leukemia
  • "Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results," 2021, published in Leukemia
  • "Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae," 2022, published in Nature Communications
  • "Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study," 2021, published in Blood Advances

Their frequent co-authors comprise a network of scientists with whom they have collaborated extensively over multiple publications, including:

  • Pau Montesinos
  • David Martínez-Cuadrón
  • Jaime Sanz
  • Juan Montoro
  • Aitana Balaguer-Roselló

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

    Peter Greenberg;Christopher Cox;Michelle M. LeBeau;Pierre Fenaux

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Francesco Rodeghiero;Roberto Stasi;Terry Gernsheimer;Marc Michel

  • International consensus report on the investigation and management of primary immune thrombocytopenia.

    Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

    Hagop M Kantarjian;Anthony Stein;Nicola Gökbuget;Adele K. Fielding

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

    Pierre Fenaux;Claude Chastang;Sylvie Chevret;Miguel Sanz

  • Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

    David J. Kuter;James B. Bussel;Roger M. Lyons;Vinod Pullarkat

  • Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

    Miguel A. Sanz;Francesco Lo Coco;Guillermo Martı́n;Giuseppe Avvisati

  • Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

    Miguel A. Sanz;Guillermo Martín;Marcos González;Angel León

  • A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

    Miguel A. Sanz;Guillermo Martı́n;Consuelo Rayón;Jordi Esteve

  • Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.

    GF Sanz;MA Sanz;T Vallespi;MC Canizo

  • Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Miguel A. Sanz;Miguel A. Sanz;Pierre Fenaux;Martin S. Tallman;Elihu H. Estey

  • Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

    Mark Levis;Farhad Ravandi;Eunice S. Wang;Maria R. Baer

  • Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy, and Cytogenetic Characteristics

    R. Garcı́a-Sanz;A. Orfão;M. González;M.D. Tabernero

  • Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia

    S. De Botton;H. Dombret;M. Sanz;J. San Miguel

  • Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

    Javier de Serna;Pau Montesinos;Edo Vellenga;Chelo Rayón

Frequent Co-Authors

Guillermo Sanz
Guillermo Sanz Hospital Universitari i Politècnic La Fe
Francesco Lo-Coco
Francesco Lo-Coco University of Rome Tor Vergata
Bob Löwenberg
Bob Löwenberg Erasmus MC
Martin S. Tallman
Martin S. Tallman Northwestern University
Pierre Fenaux
Pierre Fenaux Université Paris Cité
Arnold Ganser
Arnold Ganser Hannover Medical School
Marcos González
Marcos González University of Salamanca
Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
David Grimwade
David Grimwade King's College London
Hartmut Döhner
Hartmut Döhner University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens numerous related online degree and career opportunities. For those with an associate’s degree in nursing, adn to fnp bridge programs offer a flexible path to advanced clinical roles, making it easier to become a Family Nurse Practitioner.

Students interested in broader health topics may benefit from pursuing an online degree nutrition program. These programs can lead to careers in dietetics, wellness coaching, and public health education.

For those looking to move into management and leadership, top cahme accredited mha programs prepare graduates for administrative roles within hospitals and healthcare systems.

Registered nurses can advance their education seamlessly with rn to bsn online without clinicals options, allowing working professionals to qualify for more job opportunities and higher pay with full schedule flexibility.

Best Scientists Citing Miguel A. Sanz

Trending Scientists

Recently Published Articles